TESTING & COAS
How to Read a Peptide COA
A certificate of analysis is the document that connects a specific batch of material to the tests performed on it. Regulatory GMP guidance for active pharmaceutical ingredients describes it in exactly those terms: an authentic certificate lists each test performed, the acceptance limits, and the numerical results obtained for that batch.
Read properly, a COA tells you what was tested, by which method, when, and by whom. Read carelessly, a COA is just a number in a large font. This guide walks through each field, what it means, and where the document's authority stops.
HELIX materials are supplied for laboratory research use only and are not for human or veterinary use. Nothing here is dosing, usage or medical guidance.
Batch and lot number
The batch or lot number is the single most important field, because it is what makes the rest of the document meaningful. A COA describes one specific production batch — not a product line, not a supplier, not a compound in general.
The first check on any COA is therefore whether its batch number matches the material in front of you. If it does not, the document is not evidence about your material. HELIX prints a batch/lot number on each individual sachet, and that number resolves to the corresponding certificate in the lab results archive, so the match can be verified rather than assumed.
- One certificate describes one production batch
- Batch on the certificate must match the batch on the material
- A certificate without a batch identifier is not traceable evidence
Identity testing
Identity answers a different question from purity: is this the compound it claims to be? For a peptide the primary identity evidence is molecular mass, determined by mass spectrometry and compared against the theoretical mass calculated from the stated sequence.
A well-formed COA shows the theoretical and observed mass, and states the technique used. Where relevant, sequence-level confirmation may be supported by tandem MS or by amino acid analysis. Identity and purity should both be present — one without the other leaves an obvious gap.
- Theoretical mass from the stated sequence
- Observed mass from the mass spectrometry run
- Technique stated — for example ESI-MS or MALDI-TOF
Purity and HPLC
Peptide purity is conventionally reported by reverse-phase HPLC as an area-percent figure: the area of the main peak as a percentage of total integrated peak area at a stated detection wavelength. That definition carries two immediate consequences.
First, the number is relative to what the method detects. Species that do not absorb at the detection wavelength, do not elute under the gradient used, or co-elute with the main peak are not represented in it. Second, the number is only interpretable alongside the method — gradient, column, wavelength — and alongside evidence that the chromatographic system was performing acceptably. Pharmacopeial chromatography chapters formalise this through system suitability requirements such as resolution and reproducibility, and analytical procedures are expected to be validated for characteristics including specificity and accuracy.
A credible purity claim therefore comes with a chromatogram or, at minimum, the method parameters. A bare percentage with no method attached should be treated as an assertion rather than a result.
- Area-percent by RP-HPLC at a stated wavelength
- Method parameters — column, gradient, detection — belong on the document
- System suitability and method validation underpin the number's meaning
- Co-eluting or non-absorbing species are invisible to the figure
Mass spectrometry
Mass spectrometry is the complement to chromatography: HPLC quantifies how much of the sample is the main peak, MS establishes what that peak is. Together they form the standard identity-plus-purity pairing for synthetic peptides, and regulatory discussion of synthetic peptide products places significant emphasis on characterising the impurity profile as well as the main component.
On the certificate, look for the observed mass, the expected mass, and agreement between them within the instrument's expected tolerance. A large or unexplained discrepancy is a substantive finding, not a rounding artefact.
Other reported tests
Beyond identity and purity, certificates commonly report physical description, water or moisture content, residual solvents, counter-ion content, and net peptide content. These matter more than they first appear: for lyophilised material in particular, water and counter-ion mass are part of the total mass, so net peptide content can differ meaningfully from gross mass.
Where a test is listed, its acceptance limit and result should both appear. A test named without a result is not a test.
- Appearance and physical description
- Water/moisture content and residual solvents
- Counter-ion and net peptide content where applicable
- Each with a stated specification and an actual result
Test date and laboratory information
A COA is a snapshot. The test date tells you when the batch was assessed, which is what makes it possible to reason about the interval between testing and the material's current state. A certificate with no date cannot support any statement about the present.
The issuing laboratory should be identified, and the document should be attributable — analyst or authorised approver, and contact details. Third-party testing adds independence; in-house testing is not automatically inferior, but it should be labelled honestly so the reader knows which they are looking at.
- Test date present and specific
- Issuing laboratory named and contactable
- Clear whether testing was in-house or third-party
- Authorised approver identified
What a COA can establish
Used correctly, a COA supports a bounded set of statements: that a named batch was tested on a stated date, by named methods, at a named laboratory, and produced these results against these specifications.
That is genuinely valuable. It is the difference between a documented material and an undocumented one, and it is the basis on which a batch can be accepted, rejected, or investigated.
- That a specific batch was tested, when, and by whom
- Which methods were used and what results they produced
- Whether results met the stated specifications
What a COA cannot establish
A COA does not establish that a compound is safe, effective, suitable for any application, or approved for any use. It does not describe how material has been stored or handled since testing. It does not extend to other batches. And it does not detect what its methods were not designed to detect.
It also does not verify itself. A certificate is only as good as its traceability — which is why the batch match, the named laboratory and the published archive matter more than the headline percentage.
- No safety, efficacy or fitness-for-purpose conclusion
- No information about post-testing storage or handling
- No coverage of other batches
- No detection of analytes outside the methods used
Matching a HELIX batch to its certificate
HELIX publishes certificates at batch level rather than one document per product. Each sachet carries a batch/lot number, and entering that number in the lab results archive returns the certificate for that batch specifically.
The practical effect is that the check described at the top of this article — does the batch on the document match the batch on the material — can actually be completed, rather than taken on trust.
References
- ICH Q7 — Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (see section 11.4, Certificates of Analysis).
- ICH Q2(R2) — Validation of Analytical Procedures, adopted 1 November 2023.
- United States Pharmacopeia. General Chapter <621> Chromatography — system suitability (USP FAQ and official-text summary).
- U.S. Food and Drug Administration. Draft guidance: ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin — Federal Register notice, 3 October 2017.
- HELIX batch-level certificate of analysis archive (product documentation).
Related HELIX pages
Related articles
Research use only. HELIX materials are not for human or veterinary use. This article does not provide dosing, usage or medical guidance.